The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a cancer diagnosis. Read about the research-driven progress during National Cancer Research Month—#NCRM25: https://t.co/u8C3eiZgyb #UnitedByCancerResearch
May is National Cancer Research Month. Dr. LoRusso, AACR Past President, explains how basic research is essential to accelerating advances in cancer science and medicine. Learn more in the @AACR Cancer Progress Report: https://t.co/XlJKPVQ7sg #NCRM25#UnitedByCancerResaerch
“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” @kevansf@UCSF in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR https://t.co/Nqkjeqa6JL @aacr
Donʻt miss today, May 1st at 4pm: Maria Castro, PhD @castro2355_mg@umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our Friday Seminar Series @UCSF https://t.co/qsEwJpNcWH
We thank the more than 22,000 attendees—including more than 900 virtual attendees—from 81 countries who participated in the AACR Annual Meeting 2025 in Chicago. The #AACR25 hashtag garnered 636 million impressions from 3,852 users on X alone.
Friday, May 1st at 4pm: Maria Castro, PhD @castro2355_mg@umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our @UCSF Friday Seminar Series in Basic and Translational Research https://t.co/O5mcT4hnGC
Tues, April 30th 10:15 AM CT | @UCSF at #AACR25 | Xiaokun Shu, PhD, presents "New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation" at @aacr. Session preview: https://t.co/EbHBXm8FL0
Wednesday, April 30th 12:39 PM CT | @UCSF at #AACR25 | Plenary Session on meeting highlights and Vision for the Future. Scarlett Gomez, PhD, MPH @UCSF_Epibiostat
will present. https://t.co/jicDPDQlyG
Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML).
https://t.co/KAXArCd7Fp
🚨🧬Everything you wanted to know about actionable #neoantigens resulting from cancer mutations besides point mutations (*but were afraid to ask). Join us at 10:15 in 📍Room E351 - McCormick Lakeside Center (Level 3)! @MSKCancerCenter@UCSFCancer@institut_curie
At the #AACR25 plenary, Matthew Krummel, PhD, (@UCSFCancer) explores therapeutic strategies to reshape the tumor micro- and macroenvironment, including 12 tumor immune archetypes that may help uncover novel targeted treatments.
Read more: https://t.co/5cUOWMq5vl
#MoffittAACR25@AACR
UCSF neurosurgery experts including Drs. Shawn @HerveyJumper, @robcosorio, Praveen Mummaneni & Dr. Nima Alan presented new research & clinical findings at the prestigious @AANSNeuro Annual Scientific Meeting in Boston. #AANS2025 Details on their talks ➡️ https://t.co/UMGdwmeAQx
Check out our podium at #AUA25 tomorrow discussing upstream regulators of STEAP1 in prostate cancer, presented by Dr. Sasha Zhu
@UCSFUrology@UCSFCancer
https://t.co/qGWfTSLSli
Tuesday, April 29th 10:45 AM CT | @UCSF at #AACR25 | Major Symposium: Immunology with
Hideho Okada, MD, PhD presenting "Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens" at https://t.co/fi5fcU39ye @aacr
Tuesday, April 29th 2:50 PM CT | @UCSF at #AACR25 | @Tadashi_Manabe @bivonalab presents "Unveiling the potent anti-tumor activity and underlying mechanism of action of the novel pan-RAF inhibitor exarafenib in BRAF-mutated NSCLCr" https://t.co/yD8ePH6FI0